Sarcopenia and Inflammation with Immunotherapy
- PMID: 32191391
- PMCID: PMC7216466
- DOI: 10.1634/theoncologist.2019-1005
Sarcopenia and Inflammation with Immunotherapy
Abstract
This letter to the editor presents possible limitations of the study reported by Bilen et al., which might have affected the reported results.
Comment in
-
In Reply.Oncologist. 2020 May;25(5):e876. doi: 10.1634/theoncologist.2020-0059. Epub 2020 Mar 23. Oncologist. 2020. PMID: 32201999 Free PMC article.
Comment on
-
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.Oncologist. 2020 Mar;25(3):e528-e535. doi: 10.1634/theoncologist.2019-0751. Epub 2019 Dec 5. Oncologist. 2020. PMID: 32162807 Free PMC article.
References
-
- Aroldi F, Zaniboni A. Immunotherapy for pancreatic cancer: Present and future. Immunotherapy 2017;9:607–616. - PubMed
-
- Feng M, Xiong G, Cao Z et al. PD‐1/PD‐L1 and immunotherapy for pancreatic cancer. Cancer Lett 2017;407:57–65. - PubMed
-
- Rossi G, Pezzuto A, Sini C et al. Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario. Crit Rev Oncol Hematol 2019;142:26–34. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
